Materials for you and your practice

Download helpful materials to keep information nearby about the basics of clonoSEQ, specimen requirements, and more.

clonoSEQ HCP Brochure

Everything you need to know about clonoSEQ, including how it benefits patients, in one resource.

Looking for the patient brochure?

Looking for the patient brochure?

Step-by-step guidance on how to order clonoSEQ through the Diagnostic Portal.

Learn how clonoSEQ works, how to place an order, and about general specimen requirements at a glance.

This page is intended for a US-based audience.

clonoSEQ® is available as an FDA-cleared in vitro diagnostic (IVD) test service provided by Adaptive Biotechnologies to detect measurable residual disease (MRD) in bone marrow from patients with multiple myeloma or B-cell acute lymphoblastic leukemia (B-ALL) and blood or bone marrow from patients with chronic lymphocytic leukemia (CLL). Additionally, clonoSEQ is available for use in other lymphoid cancers and specimen types as a CLIA-validated laboratory developed test (LDT). To review the FDA-cleared uses of clonoSEQ, visit